Drug-resistant HIV has been increasing in parts of sub-Saharan Africa over the last decade, according to experts writing in the Lancet.Studies on 26,000 untreated HIV-positive people in developing countries were reviewed by the team.They said resistance could build up if people fail to stick to drug

A drug user has died in a Lancashire hospital after being infected with anthrax, the Health Protection Agency (HPA) has said.It is understood the victim is a man from north-west England. The HPA said the death happened in Blackpool and the person had injected drugs.It is the eighth case recently rep

(Reuters) – Scientists have found alarming levels of the lung disease tuberculosis in Africa, Asia, Europe and Latin America that are resistant to up to four powerful antibiotic drugs.In a large international study published in the Lancet medical journal on Thursday, researchers found rates of both

WASHINGTON — One of the few bills moving through Congress with bipartisan support this spring would speed government approval of lower-cost generic copies of brand-name drugs. But one company, with help from an influential former congressman, is lobbying to protect its most lucrative brand-name prod

The Food and Drug Administration on Monday approved the first drug shown to reduce the risk of H.I.V. infection, a milestone in the 30-year battle against the virus that causes AIDS. The agency approved Truvada, a pill made by Gilead Sciences, as a preventive measure for people who are at high risk

(Reuters Health) – A new, small study suggests medicinal marijuana may impair users’ driving skills – but might be missed by typical sobriety tests.At doses used in AIDS, cancer and pain patients, people weaved side to side more and had a slower reaction time in the hours after using the drug, resea

Asst. Prof. Dr. Wang Yi is a co-founder of Medical Innovation Development and Assessment Support (MIDAS). His research areas include early health technology assessment, traditional health technology assessment, population’s preference for health and healthcare, and economic evaluation/analysis using real-world data and observational data. He is als

Dr. Teerawat Wiwatpanit is a biomedical scientist by training. His expertise includes early health technology assessment, innovation development, and biomedical engineering for disease modeling and drug testing. He is passionate about promoting an efficient innovation landscape and translating scientific discoveries into practical healthcare soluti

Dr. Nishanta Sharma is a quantitative researcher at HITAP Thailand, currently leading a project that assesses the environmental and economic impacts of low-value healthcare services using input-output analysis, as well as exploring the nexus between climate and epidemiology. He holds a PhD in Development and Sustainability from the Asian Institute

Joshua R. Freeman, Ph.D., M.P.H., is a Researcher in the Research International Unit of the HITAP Foundation. He holds a Ph.D. in Epidemiology and an M.P.H. in Public Health. His research focuses on sleep health throughout the life course, investigating how sleep patterns and circadian rhythms influence health outcomes, and contributing to evidence